Skip to main navigation Skip to search Skip to main content

Pioglitazone in early Parkinson's disease: A phase 2, multicentre, double-blind, randomised trial

  • Tanya Simuni
  • , Karl Kieburtz
  • , Barbara Tilley
  • , Jordan J Elm
  • , Bernard Ravina
  • , Debra Babcock
  • , Marina Emborg
  • , Robert Hauser
  • , Cornelia Kamp
  • , John C. Morgan
  • , G. Webster Ross
  • , David K Simon
  • , Jacci Bainbridge
  • , Liana Baker
  • , Ivan Bodis-Wollner
  • , James Boyd
  • , Franca Cambi
  • , Julie Carter
  • , Kelvin Chou
  • , Nabila Dahodwala
    • Richard B. Dewey, Rohit Dhall, John Fang, Buff Farrow, Andrew Feigin, Sofya Glazman, John Goudreau, Pauline LeBlanc, Stephen Lee, Maureen Leehey, Mark F. Lew, Stephanie Lowenhaupt, Sheng Luo, Rajesh Pahwa, Adriana Perez, Jay Schneider, Burton Scott, Binit Shah, Kathleen M. Shannon, Saloni Sharma, Carlos Singer, Daniel Truong, Renee Wagner, Karen Williams, Anne Marie Wills, Pei Shieen Wong, Cindy Zadikoff, Richard Zweig

Research output: Contribution to journal › Article › peer-review

247 Scopus citations

Fingerprint

Dive into the research topics of 'Pioglitazone in early Parkinson's disease: A phase 2, multicentre, double-blind, randomised trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience